IONS

Ionis Pharmaceuticals

Stock NASDAQ – Stock Market Prices, News & Analysis

Ionis Pharmaceuticals Inc is a biopharmaceutical company focused on the development of RNA-based therapeutics.

$ 74.79
0.45 %

Ionis Pharmaceuticals

$ 74.79
0.45 %
IONS

Ionis Pharmaceuticals Inc is a biopharmaceutical company focused on the development of RNA-based therapeutics.

Price history of Ionis Pharmaceuticals
Price history of Ionis Pharmaceuticals

Performance & Momentum

6 Months 8.16 %
1 Year 162.24 %
3 Years 111.57 %
5 Years 76.56 %

Strategic Analysis

Ionis Pharmaceuticals • 2026

Ionis Pharmaceuticals positions itself as a pioneer in RNA therapies, focusing its business model on the discovery and development of innovative biotechnology treatments. Its differentiation lies in advanced scientific expertise and a robust portfolio of drug candidates across various therapeutic areas.

Strengths
  • Well-established leader in RNA-based technologies with a rich and diversified pipeline
  • Solid growth driven by recent clinical advancements and strategic partnerships
  • Positioned in a rapidly expanding market linked to genetic therapies
Weaknesses
  • High dependence on future clinical successes, exposing it to regulatory risk
  • Marked lack of geographical diversification, concentrated on the U.S. market
Momentum

The momentum is very favorable, reflecting a strong resurgence of investor interest driven by excellent recent performance and the valuation of clinical advancements. This positive dynamic supports a long-term growth-oriented investment strategy in innovative biotechnology.

Analysis performed 1 month ago

Similar stocks to Ionis Pharmaceuticals

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone